Contract Research & Services
Contract Research

Global Biosimilar Development

Published 23 October 2014 | By PRA Health Sciences

Many different terms are used in different parts of the world to describe “biosimilar products.” It is important to understand and differentiate true biosimilars from others because of the potential concern for patient safety and efficacy, and the misconceptions that can arise from misleading published reports.

Available Downloads

Global Biosimilar Development